《神經(jīng)精神藥理學(xué)》是一份國(guó)際科學(xué)期刊，也是美國(guó)神經(jīng)精神藥理學(xué)學(xué)院(ACNP)的官方出版物。這個(gè)雜志主要集中在臨床和基礎(chǔ)科學(xué)的貢獻(xiàn),促進(jìn)我們的大腦和行為的理解,特別是相關(guān)的分子、細(xì)胞、生理和心理的屬性代理代理在中樞神經(jīng)系統(tǒng)和新的分子靶點(diǎn)的識(shí)別發(fā)展的精神藥品的下一代。編輯部歡迎原創(chuàng)報(bào)道，也歡迎評(píng)論和觀點(diǎn)。針對(duì)該領(lǐng)域的跨學(xué)科性質(zhì),特別強(qiáng)調(diào)研究解決正常和病理行為反應(yīng)的生理機(jī)制,自然,神經(jīng)精神障礙的病因和病理生理學(xué),生物epidemeology有關(guān)方面,診斷和治療這些疾病,和精神藥理學(xué)的基本機(jī)制發(fā)揮他們的作用。

Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon the clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of new molecular targets for the development of the next generations of psychotropic drugs. While original reports are preferred, minireviews and perspectives are invited by the editorial office. In view of the interdisciplinary nature of the field, particular emphasis is placed on studies that address the biological substrates of normal and pathological behavior, the nature, etiology and pathophysiology of neuropsychiatric disorders, biologically relevant aspects of the epidemeology, diagnosis, and treatment of these disorders, and the basic mechanisms by which psychopharmacological agents exert their effect.